FDMT 4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. (FDMT) Institutional Ownership
What the institutions did with FDMT last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.
Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeLargest holders
| Manager | Shares | % of reported |
|---|---|---|
| Jupiter Topco LLC | 5.7M | 9.9% |
| RA CAPITAL MANAGEMENT, L.P. | 5.0M | 8.7% |
| BlackRock, Inc. | 4.5M | 7.8% |
| GOLDMAN SACHS GROUP INC | 4.3M | 7.3% |
| NOVO HOLDINGS A/S | 3.2M | 5.6% |
| STATE STREET CORP | 2.9M | 5.0% |
| BVF INC/IL | 2.9M | 5.0% |
| T. Rowe Price Investment Management, Inc. | 2.5M | 4.3% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.2M | 3.9% |
| Trails Edge Capital Partners, LP | 2.2M | 3.8% |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.1M | 3.6% |
| ARMISTICE CAPITAL, LLC | 2.0M | 3.4% |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1M | 1.9% |
| BANK OF AMERICA CORP /DE/ | 1.1M | 1.9% |
| Evergreen Quality Fund GP, Ltd. | 951.5K | 1.6% |
| Parkman Healthcare Partners LLC | 948.2K | 1.6% |
| DIMENSIONAL FUND ADVISORS LP | 730.9K | 1.3% |
| DEUTSCHE BANK AG\ | 710.9K | 1.2% |
| CITADEL ADVISORS LLC | 687.6K | 1.2% |
| RENAISSANCE TECHNOLOGIES LLC | 614.6K | 1.1% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 579.9K | 1.0% |
| DIADEMA PARTNERS LP | 571.1K | 1.0% |
| NORTHERN TRUST CORP | 562.9K | 1.0% |
| ACUTA CAPITAL PARTNERS, LLC | 507.8K | 0.9% |
| Nuveen, LLC | 503.1K | 0.9% |
Largest changes
| Manager | Action | Previous | Current | Change |
|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | New | 0 | 2.5M | +2.5M |
| FEDERATED HERMES, INC. | Reduced | 1.4M | 222.4K | -1.2M |
| Trails Edge Capital Partners, LP | Increased | 1.3M | 2.2M | +925.0K |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Increased | 1.6M | 2.2M | +644.0K |
| DIADEMA PARTNERS LP | New | 0 | 571.1K | +571.1K |
| ACUTA CAPITAL PARTNERS, LLC | New | 0 | 507.8K | +507.8K |
| Catalio Capital Management, LP | New | 0 | 471.3K | +471.3K |
| Parkman Healthcare Partners LLC | Increased | 522.6K | 948.2K | +425.6K |
| CITADEL ADVISORS LLC | Increased | 264.1K | 687.6K | +423.5K |
| NOVO HOLDINGS A/S | Reduced | 3.7M | 3.2M | -401.6K |
| BlackRock, Inc. | Increased | 4.1M | 4.5M | +400.8K |
| Schonfeld Strategic Advisors LLC | Increased | 101.1K | 407.5K | +306.4K |
| Peapod Lane Capital LLC | Sold Out | 241.5K | 0 | -241.5K |
| Opaleye Management Inc. | Increased | 112.3K | 334.4K | +222.1K |
| NORTHERN TRUST CORP | Increased | 342.0K | 562.9K | +220.9K |
| DIMENSIONAL FUND ADVISORS LP | Increased | 522.8K | 730.9K | +208.0K |
| STATE STREET CORP | Increased | 2.7M | 2.9M | +203.2K |
| Brevan Howard Capital Management LP | New | 0 | 176.9K | +176.9K |
| Invesco Ltd. | Reduced | 310.7K | 150.4K | -160.3K |
| MORGAN STANLEY | Increased | 345.4K | 503.0K | +157.6K |
| BANK OF AMERICA CORP /DE/ | Increased | 974.2K | 1.1M | +146.5K |
| Persistent Asset Partners Ltd | New | 0 | 145.6K | +145.6K |
| ACADIAN ASSET MANAGEMENT LLC | Increased | 20.1K | 163.5K | +143.4K |
| Exome Asset Management LLC | Sold Out | 130.6K | 0 | -130.6K |
| Propel Bio Management, LLC | Reduced | 380.4K | 252.7K | -127.8K |
13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.